Sunday 11 October 2026
Export all MKSI data to Excel Powerpack
MKS Inc.
MKSI Technology Scientific & Technical Instruments
MKS Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 9.62% from fiscal 2024. In the quarter to June 2026, revenue grew 28.3%, EPS grew 181.5%, free cash flow grew 39.0% and total debt fell 10.5%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
264.50
4.12
+1.58%
Follow MKSI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
68.12 | 47.29 | 36.40 | 29.97 |
+8 more quarters Free account |
P/S ratio |
6.92 | 3.80 | 2.74 | 2.17 | |
P/FCF ratio |
65.65 | 38.24 | 21.51 | 15.69 | |
P/Operating CF |
123.74 | 292.25 | 75.74 | 42.28 | |
P/B ratio |
10.06 | 5.51 | 3.96 | 3.20 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
7.68 | 4.66 | 3.63 | 3.12 | |
EV/EBITDA |
31.93 | 20.31 | 15.90 | 13.38 | |
EV/Operating CF |
52.60 | 34.05 | 22.14 | 17.58 | |
EV/FCF |
72.93 | 46.84 | 28.56 | 22.48 | |
Quick Ratio |
0.59 | 0.59 | 1.43 | 1.48 | |
Current Ratio |
1.14 | 1.11 | 2.71 | 2.86 | |
Net Debt/EBITDA |
9.77 | 14.62 | 14.94 | 15.61 | |
Debt/Assets |
44.10% | 46.38% | 47.76% | 49.04% | |
Debt/Equity |
1.32 | 1.44 | 1.55 | 1.66 | |
Asset Turnover |
0.49 | 0.47 | 0.45 | 0.43 | |
Operating CF/Net income |
1.39 | 0.63 | 1.33 | 2.66 | |
Capex/Depreciation |
(0.60) | (0.28) | (0.51) | (0.55) | |
Interest Coverage |
6.61 | 3.31 | 2.82 | 2.60 | |
Research and Development Expense of Revenue |
6.09% | 7.51% | 7.45% | 7.69% | |
Selling, General and Administrative Expense of Revenue |
16.03% | 17.63% | 17.79% | 18.22% | |
Intangible Assets out of Total Assets |
0.51 | 0.53 | 0.54 | 0.54 | |
Share Based Compensation of Revenue |
1.20% | 1.76% | 0.87% | 1.21% | |
Graham Net Nets |
(0.11) | (0.22) | (0.33) | (0.44) | |
Graham Number |
80.59 | 67.53 | 63.17 | 59.92 | |
Earnings Yield |
1.47% | 2.11% | 2.75% | 3.34% | |
Free Cash Flow Yield |
1.52% | 2.61% | 4.65% | 6.37% | |
Revenue per Share |
18.46 | 15.99 | 15.36 | 14.68 | |
Operating CF per Share |
3.59 | 0.79 | 2.11 | 2.93 | |
Capex per Share |
(0.80) | (0.37) | (0.70) | (0.76) | |
Free Cash Flow per Share |
2.80 | 0.42 | 1.41 | 2.17 | |
Cash per Share |
9.04 | 8.44 | 10.03 | 10.36 | |
Shareholders Equity per Share |
44.20 | 41.71 | 40.40 | 38.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
44.20 | 41.71 | 40.40 | 38.63 | |
Free Cash Flow |
189.00 | 28.00 | 95.00 | 146.00 | |
Working Capital |
350.00 | 254.00 | 1,583.00 | 1,650.00 | |
Capital Expenditures |
(54.00) | (25.00) | (47.00) | (51.00) | |
Net Current Asset Value |
(3,179.00) | (3,372.00) | (3,567.00) | (3,641.00) | |
EV/EBIT |
48.97 | 33.51 | 27.05 | 22.91 | |
Capex to Sales |
0.04 | 0.02 | 0.05 | 0.05 | |
Price to Operating Income |
44.09 | 27.37 | 20.37 | 15.99 | |
| Other line items | |||||
Average Receivables |
739.50 | 707.00 | 633.00 | 610.00 | |
Average Payables |
444.50 | 385.50 | 374.00 | 344.00 | |
Average Inventory |
975.50 | 921.50 | 907.00 | 937.00 | |
Average Assets |
8,883.50 | 8,642.00 | 8,693.00 | 8,900.00 | |
Average Common Equity |
2,770.50 | 2,582.50 | 2,520.50 | 2,499.00 |
Columns are period end dates